COO - Insider Transaction: Agostino Ricupati Sells $5.52M Worth Of Cooper Companies Shares | Benzinga
Agostino Ricupati, SVP & CAO at Cooper Companies (NASDAQ:COO), executed a substantial insider sell on March 20, according to an SEC filing.
What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, Ricupati sold 54,724 shares of Cooper Companies. The total transaction value is $5,521,230.
The latest market snapshot at Thursday morning reveals Cooper Companies shares down by 0.0%, trading at $101.66.
Discovering Cooper Companies: A Closer Look
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
Understanding the Numbers: Cooper Companies's Finances
Revenue Growth: ...